Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Questions? Contact CDC-INFO    

Figure L. Decreased Susceptibility to Azithromycin Among GISP Isolates, 1990-2008

This web page is archived for historical purposes and is no longer being updated.

CLINIC% of isolates
19921993199419951996199719981999200020012002200320042005200620072008
ALBUQUERQUE.0.7...........2.3.0.6.
ATLANTA........0.41.50.82.85.2....
BALTIMORE.............0.7...
BIRMINGHAM..........0.30.7.1.0...
CHICAGO............1.01.8.1.10.4
CINCINNATI............0.30.7...
CLEVELAND....0.4............
DALLAS.............0.70.3..
DENVER.........0.71.3....2.8.
DETROIT.................
GREENSBORO...........1.3.....
HONOLULU.......2.0.1.3...1.11.1.3.8
KANSAS CITY....0.4..3.80.7.......0.8
LAS VEGAS...........0.31.41.00.72.7.
LOS ANGELES............0.41.0.1.2.
MIAMI.................
MINNEAPOLIS....1.7.0.4.....0.81.20.4..
NEW ORLEANS.........0.8.......
NEW YORK CITY...............0.60.8
OKLAHOMA CITY.................
ORANGE COUNTY........0.9.0.60.6..3.8..
PHILADELPHIA......0.4....0.3.0.30.3.0.4
PHOENIX.......0.4....0.3...0.8
PORTLAND..............0.61.4.
RICHMOND.................
SAN DIEGO........0.4.0.4.2.01.4.0.5.
SAN FRANCISCO........0.30.3.0.40.31.00.30.30.5
SEATTLE........0.5.0.40.4.0.70.40.5.

Decreased susceptibility to azithromycin is defined here as ≥ 2.0 µg/ml.

 
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC-INFO